MedPath

Clinical and neuropsychological factors associated with second generation antipsychotic response in patients diagnosed with first episode of early onset schizophrenia spectrum disorders

Conditions
First episode of early onset schizophrenia spectrum disorders
MedDRA version: 14.1Level: LLTClassification code 10040705Term: Simple schizophreniaSystem Organ Class: 10037175 - Psychiatric disorders
Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Registration Number
EUCTR2009-017024-82-ES
Lead Sponsor
FUNDACIÓN SANT JOAN DE DE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
0
Inclusion Criteria

1. Patients of both sexes, aged 8 to 19 years, both inclusive.
2. Score of at least moderate severity on one of the positive psychotic symptom ratings of the PANSS or BPRS-C.
3. Meet DSM-IV criteria for first episode of schizophrenia, schizophreniform, schizoaffective disorder.
4. Patients with reproductive potential will use an effective birth control method during the entire duration of the trial. Women of reproductive age will be included after a negative pregnancy test result.
5. Informed consent of parents or legal guardian and informed assent of a mature minor.
Are the trial subjects under 18? yes
Number of subjects for this age range: 70
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. History of appropriate treatment with paliperidone, aripiprazole or haloperidol (defined as at least 8 weeks of treatment with doses of paliperidone 12 mg/d, aripiprazole 30 mg/d, haloperidol 8 mg/d during the final 2 weeks of treatment) during current psychotic episode.
2. History of appropriate antipsychotic treatment (8-16 weeks) with the study drugs during a previous episode.
3. Hypersensitivity to paliperidone, aripiprazole or haloperidol or presence of any contraindications to start any of these treatments depending on technical data sheet.
4. Bipolar disorder, primary posttraumatic stress disorder, primary personality disorder, diagnosed by a doctor and confirmed by KID-SCID
5. Current major depressive disorder that is clearly defined and therefore excludes diagnosis of EOSS.
6. Premorbid diagnosis of mental retardation
7. Endocrinological or neurological conditions that confound the diagnosis or are a contraindication to treatment (concurrent organic disease that is clearly defined and therefore excludes diagnosis of EOSS).
8. Pregnant or breastfeeding

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath